Table I.
Clinical characteristics of patients with glioblastoma according to long non-coding RNA KTN-AS1 level in tissues (n=35).
| KTN1-AS1 expression | ||||
|---|---|---|---|---|
| Variables | n | Low | High | P-value |
| Age, years | ||||
| <60 | 14 | 9 | 5 | 0.129 |
| ≥60 | 21 | 8 | 13 | |
| Sex | ||||
| Male | 18 | 4 | 14 | 0.001a |
| Female | 17 | 13 | 4 | |
| Karnofsky performance scale score | ||||
| <60 | 18 | 8 | 10 | 0.615 |
| ≥60 | 17 | 9 | 8 | |
| Mean tumor diameter, cm | ||||
| <5 | 21 | 6 | 15 | 0.004a |
| ≥5 | 14 | 11 | 3 | |
| Necrosis on MRI | ||||
| Yes | 14 | 7 | 7 | 0.89 |
| No | 21 | 10 | 11 | |
| Seizure | ||||
| Yes | 17 | 9 | 8 | 0.615 |
| No | 18 | 8 | 10 | |
a
P<0.05. KTN1-AS1, Kinectin 1 Antisense RNA 1; MRI, magnetic resonance imaging.